Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Oliver Distler
Treatment With Imatinib Prevents Fibrosis in Different Preclinical Models of Systemic Sclerosis and Induces Regression of Established Fibrosis
Arthritis & Rheumatism
‹
1
2
3
Related publications
Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Semaphorin4A Coordinately Induces Inflammation and Fibrosis in Systemic Sclerosis
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
FRI0419 Intravenous Immunoglobulins Prevents Experimental Fibrosis in a Murine Model of Systemic Sclerosis
Adjunct Treatment of Recalcitrant Hand Plaques in Nephrogenic Systemic Fibrosis After Imatinib Therapy
SKIN The Journal of Cutaneous Medicine
Vascular Endothelial Growth Factor Aggravates Fibrosis and Vasculopathy in Experimental Models of Systemic Sclerosis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
Frontiers in Immunology
Allergy
Immunology
548 Inhibitory Regulation of MFG-E8 on Fibrosis in Systemic Sclerosis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Integrin-Modulating Therapy Prevents Fibrosis and Autoimmunity in Mouse Models of Scleroderma
Nature
Multidisciplinary
Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis
Current Rheumatology Reviews
Rheumatology